Drug Discovery & Development
In vitro models
These tests are performed depending on the role of the therapeutic antibody to be designed. If the antibody must be able to activate an immune response by triggering NK cells and bispecific antibodies, cell-mediated cytotoxicity will be used. In the case of an antibody with a target expressed on the surface of the cancer cells, direct cytotoxicity testing could be performed.
Further details on the project may be requested directly by the expert. You will be able to exchange directly with the experts after filling in the form below.
Please answer all questions below to specify your requirements
Please answer all questions. If you are not logged in, you will be redirected.